Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -907.30K | -1.03M | -942.20K | -1.06M | -880.50K |
| Total Depreciation and Amortization | 164.20K | 172.00K | 179.30K | 182.30K | 185.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.60K | 100.50K | 90.20K | 95.60K | 87.10K |
| Change in Net Operating Assets | 287.80K | 510.80K | 72.70K | 176.80K | 270.30K |
| Cash from Operations | -358.70K | -242.90K | -600.00K | -610.20K | -337.30K |
| Capital Expenditure | -91.00K | -104.50K | -96.90K | -91.70K | -56.50K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 2.80K | 2.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.00K | 87.50K | 140.00K | 192.50K | 210.00K |
| Cash from Investing | -56.00K | -17.00K | 43.10K | 103.60K | 156.30K |
| Total Debt Issued | 307.40K | 307.40K | 390.00K | 321.40K | 271.40K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 307.40K | 307.40K | 390.00K | 321.40K | 271.40K |
| Foreign Exchange rate Adjustments | -40.10K | -150.30K | -45.80K | -52.80K | -28.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.30K | -102.60K | -212.50K | -237.80K | 61.80K |
